Cite
Cost-effectiveness of immune checkpoint inhibitors and radiotherapy in advanced non-small cell lung cancer.
MLA
Giuliani, Jacopo, and Francesco Fiorica. “Cost-Effectiveness of Immune Checkpoint Inhibitors and Radiotherapy in Advanced Non-Small Cell Lung Cancer.” Journal of Oncology Pharmacy Practice, vol. 27, no. 8, Dec. 2021, pp. 2004–06. EBSCOhost, https://doi.org/10.1177/10781552211038925.
APA
Giuliani, J., & Fiorica, F. (2021). Cost-effectiveness of immune checkpoint inhibitors and radiotherapy in advanced non-small cell lung cancer. Journal of Oncology Pharmacy Practice, 27(8), 2004–2006. https://doi.org/10.1177/10781552211038925
Chicago
Giuliani, Jacopo, and Francesco Fiorica. 2021. “Cost-Effectiveness of Immune Checkpoint Inhibitors and Radiotherapy in Advanced Non-Small Cell Lung Cancer.” Journal of Oncology Pharmacy Practice 27 (8): 2004–6. doi:10.1177/10781552211038925.